Shenzhen Neptunus Bioengineering Co Ltd (000078) - Total Liabilities
Based on the latest financial reports, Shenzhen Neptunus Bioengineering Co Ltd (000078) has total liabilities worth CN¥23.58 Billion CNY (≈ $3.45 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shenzhen Neptunus Bioengineering Co Ltd (000078) investment intensity to see how much of total assets are deployed in long-term investments.
Shenzhen Neptunus Bioengineering Co Ltd - Total Liabilities Trend (1995–2025)
This chart illustrates how Shenzhen Neptunus Bioengineering Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Shenzhen Neptunus Bioengineering Co Ltd.
Shenzhen Neptunus Bioengineering Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shenzhen Neptunus Bioengineering Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kunming Yunnei Power Co Ltd
SHE:000903
|
China | CN¥9.00 Billion |
|
CJ CGV
KO:079160
|
Korea | ₩3.81 Trillion |
|
Guangdong Piano Customized Furniture Co Ltd
SHE:002853
|
China | CN¥456.96 Million |
|
TOMTOM N.V.ADRS 1/2 EO-20
F:OEMB
|
Germany | €565.10 Million |
|
Kvika banki hf
IC:KVIKA
|
Iceland | Ikr295.12 Billion |
|
Fujian SuperTech Advanced Material Co Ltd
SHG:688398
|
China | CN¥945.69 Million |
|
Mattr Corp
TO:MATR
|
Canada | CA$849.48 Million |
|
Jiujiang Shanshui Technology Co.Ltd
SHE:301190
|
China | CN¥209.60 Million |
Liability Composition Analysis (1995–2025)
This chart breaks down Shenzhen Neptunus Bioengineering Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Shenzhen Neptunus Bioengineering Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 18.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shenzhen Neptunus Bioengineering Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shenzhen Neptunus Bioengineering Co Ltd (1995–2025)
The table below shows the annual total liabilities of Shenzhen Neptunus Bioengineering Co Ltd from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥24.16 Billion ≈ $3.53 Billion |
-6.93% |
| 2024-12-31 | CN¥25.95 Billion ≈ $3.80 Billion |
-7.59% |
| 2023-12-31 | CN¥28.09 Billion ≈ $4.11 Billion |
-6.82% |
| 2022-12-31 | CN¥30.14 Billion ≈ $4.41 Billion |
-0.51% |
| 2021-12-31 | CN¥30.30 Billion ≈ $4.43 Billion |
-6.00% |
| 2020-12-31 | CN¥32.23 Billion ≈ $4.72 Billion |
-3.26% |
| 2019-12-31 | CN¥33.32 Billion ≈ $4.88 Billion |
-1.92% |
| 2018-12-31 | CN¥33.97 Billion ≈ $4.97 Billion |
+39.25% |
| 2017-12-31 | CN¥24.39 Billion ≈ $3.57 Billion |
+126.22% |
| 2016-12-31 | CN¥10.78 Billion ≈ $1.58 Billion |
+1.55% |
| 2015-12-31 | CN¥10.62 Billion ≈ $1.55 Billion |
+35.29% |
| 2014-12-31 | CN¥7.85 Billion ≈ $1.15 Billion |
+28.02% |
| 2013-12-31 | CN¥6.13 Billion ≈ $897.19 Million |
+27.56% |
| 2012-12-31 | CN¥4.81 Billion ≈ $703.35 Million |
+24.38% |
| 2011-12-31 | CN¥3.86 Billion ≈ $565.47 Million |
+19.08% |
| 2010-12-31 | CN¥3.25 Billion ≈ $474.87 Million |
+31.27% |
| 2009-12-31 | CN¥2.47 Billion ≈ $361.76 Million |
+23.81% |
| 2008-12-31 | CN¥2.00 Billion ≈ $292.19 Million |
-9.97% |
| 2007-12-31 | CN¥2.22 Billion ≈ $324.56 Million |
-16.42% |
| 2006-12-31 | CN¥2.65 Billion ≈ $388.31 Million |
-16.58% |
| 2005-12-31 | CN¥3.18 Billion ≈ $465.46 Million |
+39.76% |
| 2004-12-31 | CN¥2.28 Billion ≈ $333.03 Million |
-11.99% |
| 2003-12-31 | CN¥2.59 Billion ≈ $378.42 Million |
+89.30% |
| 2002-12-31 | CN¥1.37 Billion ≈ $199.91 Million |
+27.81% |
| 2001-12-31 | CN¥1.07 Billion ≈ $156.41 Million |
+68.71% |
| 2000-12-31 | CN¥633.55 Million ≈ $92.71 Million |
+45.11% |
| 1999-12-31 | CN¥436.59 Million ≈ $63.89 Million |
+725.49% |
| 1998-12-31 | CN¥52.89 Million ≈ $7.74 Million |
-39.90% |
| 1997-12-31 | CN¥88.00 Million ≈ $12.88 Million |
+31.62% |
| 1996-12-31 | CN¥66.86 Million ≈ $9.78 Million |
+120.11% |
| 1995-12-31 | CN¥30.37 Million ≈ $4.44 Million |
-- |
About Shenzhen Neptunus Bioengineering Co Ltd
Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, manufacturing, and distribution of pharmaceuticals in China. The company also provides distribution of medical devices, and other medical supplies, as well as related value-added services. It serves medical institutions, drug retailers, and distributors. Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 19… Read more